<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig00082">
 <label>Fig. 8.2</label>
 <caption>
  <p>cGMP production facilities for NVCP VLP vaccine. (
   <bold>a</bold>) The design of the central bioprocessing suite. The arrows indicate the unidirectional flow of in-process materials (
   <italic>green</italic>), purified final product (
   <italic>red</italic>), and people (
   <italic>yellow</italic>). (
   <bold>b</bold>) The BSL-2 greenhouse facility for plant biomass generation and NVCP expression. (
   <bold>c</bold>) The Plant Biopharmaceutical Center that houses the central bioprocessing suite, the QA/QC laboratory, and the Process Development laboratory (Adapted with kind permission from Springer Science + Business Media: Plant Cell Reports, Lai and Chen [
   <xref ref-type="bibr" rid="CR0008126">126</xref>], Fig. 
   <xref rid="Fig00081" ref-type="fig">1</xref>)
  </p>
 </caption>
 <graphic xlink:href="302300_1_En_8_Fig2_HTML" id="MO00082" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
